Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email publishing@financialexpress.net in the first instance.

 Information  X 
Enter a valid email address

Kings Arms Yard (KAY)

  Print      Mail a friend       Annual reports

Thursday 17 May, 2012

Kings Arms Yard

Interim Management Statement

Interim Management Statement

KINGS ARMS YARD VCT PLC
INTERIM MANAGEMENT STATEMENT

Introduction
I am pleased to present Kings Arms Yard VCT PLC's interim management statement for the period from 1 January 2012 to 17 May 2012 as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

Performance and dividends
The Company's unaudited net asset value (NAV), based on management accounts, as at 31 March 2012 was £34.0 million, including cash balances and liquid asset balances of £7.9 million (31 December 2011: NAV £35.0 million, cash and liquid asset balances of £10.7 million) or 16.2 pence per share (31 December 2011: 16.7 pence per share). 

The net asset value for 31 March 2012 is after accounting for the forthcoming dividend of 0.5 pence per share which will be paid on 25 May 2012 to shareholders on the register on 27 April 2012.

After taking into account the dividend, the Company's net asset value has remained steady since 31 December 2011. Management fees and other expenses having been offset by an increase in the valuation of Celldex Therapeutics Inc a company quoted on the New York Stock Exchange.

Portfolio
The following investments have been made during the period from 1 January 2012 to 17 May 2012:

Name£000's
Alto Prodotto Wind Limited (further investment) 692 Installs and operates commercial scale wind installations
The Street by Street Solar Programme Limited (further investment) 485 Photo-voltaic installations
AVESI Limited (new investment) 460 Installs and operates commercial scale wind installations
Regenerco Renewable Energy Limited (further investment) 420 Photo-voltaic installations
Sift Limited (further investment) 353 Web based online business and community management solutions.
Greenenerco Limited (new investment) 300 Installs and operates commercial scale wind installations
Perpetuum Limited (further investment) 159 Manufacture and sale of microgenerators
Oxford Immunotec Limited (further investment) 171 Develops and sells T-cell measurement diagnostic products.

Disposals
During the period from 1 January 2012 to 17 May 2012, part of the Company's holding in Celldex Therapeutics Inc was sold generating proceeds of £110,000, realising a gain of £52,000 on the carrying value as at 31 December 2011.  Hilson Moran Holdings Limited made a partial loan stock repayment of £45,000.

Top ten holdings as at 31 March 2012:

InvestmentCarrying value
£000's
UniServity Limited 3,860
Elateral Holdings Limited 3,817
Workshare Limited 2,257
Vivacta Limited 1,938
Cluster Seven Limited 1,668
Oxford Immunotec Limited 1,433
Sift Limited 1,135
Hilson Moran Holdings Limited 1,182
Alto Prodotto Wind Limited 1,003
The Street by Street Solar Programme Limited 1,000

Material Events and Transactions
During the period from 1 January 2012 to 17 May 2012, the Company did not issue or buy back shares.

The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders.  Details of this Scheme can be found at www.albion-ventures.co.uk/Our Funds/Kings Arms Yard PLC.

There have been no further significant events or transactions that the Board is aware of which would have a material impact on the financial position of the Company between 1 January 2012 to 17 May 2012. However, the Board notes that it is in advanced discussions to sell one of its holdings.  Since there is no certainty the sale will complete, no change has been made to the valuation at this stage.  However, if the transaction were to take place, and depending on any performance criteria required under the relevant acquisition agreement, then it may result in a material uplift in the net asset value. 

In view of the above, the Board considers that the Company is currently unable to purchase any of its own shares in the market.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's website under www.albion-ventures.co.uk/Our Funds/Kings Arms Yard VCT.

Robin Field, Chairman
17 May 2012
For further information please contact:
Patrick Reeve, Albion Ventures LLP - tel: 020 7601 1850




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Kings Arms Yard VCT PLC via Thomson Reuters ONE

HUG#1613053